These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2412231)

  • 1. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
    J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens.
    Dillner J; Kallin B; Ehlin-Henriksson B; Rymo L; Henle W; Henle G; Klein G
    Int J Cancer; 1986 Feb; 37(2):195-200. PubMed ID: 2417963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.
    Dillner J; Sternås L; Kallin B; Alexander H; Ehlin-Henriksson B; Jörnvall H; Klein G; Lerner R
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4652-6. PubMed ID: 6205400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
    Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
    J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
    Rowe M; Finke J; Szigeti R; Klein G
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
    Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
    Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB; Pope JH; Hazelton RA
    Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen.
    Luka J; Kreofsky T; Pearson GR; Hennessy K; Kieff E
    J Virol; 1984 Dec; 52(3):833-8. PubMed ID: 6208381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.
    Billings PB; Hoch SO; White PJ; Carson DA; Vaughan JH
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7104-8. PubMed ID: 6316343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
    Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH
    J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
    Sabbatini A; Bombardieri S; Migliorini P
    Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1.
    Inoue N; Kuranari J; Harada S; Nakajima H; Ohbayashi M; Nakamura Y; Miyasaka N; Ezawa K; Ban F; Yanagi K
    J Clin Microbiol; 1992 Jun; 30(6):1442-8. PubMed ID: 1320628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.